The purpose of this study is to develop and validate a deep learning algorithm for the diagnosis of colorectal cancer other colorectal disease by marking and analyzing the characteristics of hyperspectral images based on the pathological results of colonoscopic biopsy, so as to improve the objectiveness and intelligence of early colorectal cancer diagnosis.
Prospectively collect the hyperspectral image information of ordinary colonoscopic biopsy tissue. The colonoscopic biopsy tissue is from the Endoscopy Center of Qilu Hospital of Shandong University. The hyperspectral images are marked based on the biopsy pathological results, and the deep convolutional neural network (DCNN) model is used. With training and verification, develop the Hyperspectral Imaging Artificial Intelligence Diagnostic System (HSIAIDS) .A portion of colonoscopic biopsy tissue will be collected as a prospective test set to prospectively test the diagnostic performance of the HSIAIDS algorithm.
Study Type
OBSERVATIONAL
Enrollment
86
Qilu hosipital
Jinan, Shandong, China
Accuracy of HSI artificial intelligence model to identify colorectal adenoma and cancer
Accuracy of hyperspectral imaging (HSI) artificial intelligence model to identify colorectal hyperplastic polyp, adenoma, SSL and colorectal cancer. Accuracy of artificial intelligence models Accuracy = (true positives + true negatives) / total number of subjects \* 100%
Time frame: 1 year
Sensitivity
Sensitivity of HSI artificial intelligence model Sensitivity = number of true positives / (number of true positives + number of false negatives) \* 100%.
Time frame: 1 year
Specificity
Specificity of HSI Artificial Intelligence Model Specificity = number of true negatives / (number of true negatives + number of false positives))\*100%
Time frame: 1 year
Negative predictive values(NPV)
Negative predictive values for HSI artificial intelligence model = number of true negatives / (number of true negatives + number of false negatives)\*100%
Time frame: 1 year
AUC (95% CI)
area under the receiver operating characteristic curve (AUC)
Time frame: 1 year
To record and evaluate any unknown risks and adverse events of hyperspectral imaging in specimen image acquisition
To record and evaluate any unknown risks and adverse events of hyperspectral imaging in specimen image acquisition
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.